Abstract:Prion diseases are a group of infectious neurodegenerative diseases produced by the conversion of the normal prion protein (PrP C ) into the disease-associated form (PrP Sc ). Extensive evidence indicate that the main or sole component of the infectious agent is PrP Sc , which can replicate in affected individuals in the absence of nucleic acids. However, the mechanism of PrP C -to-PrP Sc conversion remains elusive, which has been attributed to the lack of sufficient structural information of infectious PrP Sc and a reliable system to study prion replication in vitro . In this article we adapted the Protein Misfolding Cyclic Amplification (PMCA) technology for rapid and efficient generation of highly infectious prions in large-scale. Murine prions of the RML strain were efficiently propagated in volumes up to 1,000-fold larger than conventional PMCA. The large-scale PMCA (LS-PMCA) procedure enabled to produce highly infectious prions, which maintain the strain properties of the seed used to begin the reaction. LS-PMCA was shown to work with various species and strains of prions, including mouse RML and 301C strains, hamster Hyper prion, cervid CWD prions, including a rare Norwegian CWD prion, and human CJD prions. We further improved the LS-PMCA into a bioreactor format that can operate under industry-mimicking conditions for continuous and unlimited production of PrP Sc without the need to keep adding brain-derived prions. In our estimation, this bioreactor can produce in 1d an amount of prions equivalent to that present in 25 infected animals at the terminal stage of the disease. Our LS-PMCA technology may provide a valuable tool to produce large quantities of well-defined and homogeneous infectious prions for biological and structural studies.

Establishment of a Special Platform for the Research of Prion and the Diagnosis of Human Prion Disease - China's Studies

Extensive Disturbances of Intracellular Components and Dysfunctions of Biological Pathways in the Brain Tissues During Prion Infection — China’s Studies

Activation of Innate Immunity and Autophagy in Brain Tissues with Prion Disease and Degradation of Abnormal PrPs in Cells — China’s Studies

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Preparations of Specific Antibodies Against PrP N-terminal or C-terminal Peptides and Preliminary Study on Establishment of ELISA Diagnostic Method

Characteristics of Different Types of Prion Diseases - China's Surveillance.

The importance of prion research

[Establishment of a Prion Disease PrP(Sc) Panel from the Brain Tissues of Experimental Hamsters Infected with Scrapie Agent 263K].

Optimization of the Isolation and Enrichment of S-Nitrosylated Proteins from Brain Tissues of Rodents and Humans with Various Prion Diseases for Itraq-Based Proteomics

Establishment of A Stable Prpsc Panel from Brain Tissues of Experimental Hamsters with Scrapie Strain 263K

Human Prion Disease with a G114V Mutation and Epidemiological Studies in a Chinese Family: a Case Series

A Panel of Monoclonal Antibodies Against the Prion Protein Proves That There is No Prion Protein in Human Pancreatic Ductal Epithelial Cells

Establishment of Hamster- and Human-Prnp Transgenic Mice.

Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions

New implications for prion diseases therapy and prophylaxis

Analyses of the Survival Time and the Influencing Factors of Chinese Patients with Prion Diseases Based on the Surveillance Data from 2008-2011

Diagnostic and prognostic value of human prion detection in cerebrospinal fluid

Generation and Identification of Phage Engineering Antibodies Library Against Hamster Prion Protein

Expression and purification of human PrP-like protein Shadoo and preparation of antibody against Shadoo

Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease

Development of a methodology for large-scale production of prions for biological and structural studies